We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-7.81%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$500M
AUM Growth
+$252M
Cap. Flow
+$324M
Cap. Flow %
64.84%
Top 10 Hldgs %
13.81%
Holding
671
New
305
Increased
110
Reduced
50
Closed
206

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$9.4M
2
EW icon
Edwards Lifesciences
EW
+$9.31M
3
ADBE icon
Adobe
ADBE
+$7.94M
4
NOW icon
ServiceNow
NOW
+$7.5M
5
IBM icon
IBM
IBM
+$7.43M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$3.68M
2
PEP icon
PepsiCo
PEP
+$3.22M
3
DAR icon
Darling Ingredients
DAR
+$3.05M
4
WDAY icon
Workday
WDAY
+$3.02M
5
D icon
Dominion Energy
D
+$2.26M

Sector Composition

Rank Sector Weight
1 Technology 19.17%
2 Consumer Discretionary 15.27%
3 Healthcare 14.54%
4 Financials 13.32%
5 Industrials 11.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
H icon
376
Hyatt Hotels
H
$16.4B
$301K 0.06%
+3,719
New +$316K
TMDX icon
377
Transmedics
TMDX
$2.79B
$301K 0.06%
+7,210
New +$314K
BPOP icon
378
Popular Inc
BPOP
$11.2B
$300K 0.06%
+4,163
New +$324K
TRMB icon
379
Trimble
TRMB
$13.9B
$300K 0.06%
5,534
-12,178
-69% -$770K
IPGP icon
380
IPG Photonics
IPGP
$3.99B
$299K 0.06%
+3,546
New +$337K
TS icon
381
Tenaris
TS
$29.3B
$299K 0.06%
11,559
-4,310
-27% -$114K
AXSM icon
382
Axsome Therapeutics
AXSM
$10.9B
$297K 0.06%
+6,665
New +$333K
DLTR icon
383
Dollar Tree
DLTR
$25.1B
$296K 0.06%
+2,174
New +$338K
ESNT icon
384
Essent Group
ESNT
$6.14B
$296K 0.06%
+8,503
New +$341K
JKHY icon
385
Jack Henry & Associates
JKHY
$11.1B
$294K 0.06%
+1,612
New +$316K
TRP icon
386
TC Energy
TRP
$68.1B
$290K 0.06%
+7,199
New +$357K
YPF icon
387
YPF
YPF
$19.5B
$290K 0.06%
+46,688
New +$224K
AEL
388
DELISTED
American Equity Investment Life Holding Company
AEL
$290K 0.06%
+7,788
New +$292K
AAPL icon
389
Apple
AAPL
$4.52T
$288K 0.06%
2,087
-3,282
-61% -$515K
AYI icon
390
Acuity Brands
AYI
$10.4B
$285K 0.06%
1,808
-1,198
-40% -$203K
BSX icon
391
Boston Scientific
BSX
$71.1B
$284K 0.06%
+7,326
New +$294K
TCBI icon
392
Texas Capital Bancshares
TCBI
$4.41B
$282K 0.06%
+4,769
New +$282K
ALLO icon
393
Allogene Therapeutics
ALLO
$656M
$281K 0.06%
+26,013
New +$353K
EDIT icon
394
Editas Medicine
EDIT
$425M
$281K 0.06%
+22,963
New +$358K
AYX
395
DELISTED
Alteryx Inc
AYX
$279K 0.06%
+4,992
New +$293K
MTZ icon
396
MasTec
MTZ
$21.8B
$278K 0.06%
+4,381
New +$339K
PACB icon
397
Pacific Biosciences
PACB
$447M
$278K 0.06%
+47,806
New +$274K
INSM icon
398
Insmed
INSM
$21.4B
$276K 0.06%
+12,814
New +$307K
RMD icon
399
ResMed
RMD
$32.4B
$276K 0.06%
1,265
+46
+4% +$10.5K
FIGS icon
400
FIGS
FIGS
$1.81B
$275K 0.06%
+33,305
New +$354K

Similar funds

Seven Eight Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Seven Eight Capital held 671 positions worth $500M, up 102% from $248M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Seven Eight Capital deployed $324M of net new capital in Q3 2022, opening 305 new positions and adding to 110 existing holdings. Its largest new stake was Advanced Micro Devices: 110,402 shares worth $7M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Dominion Energy, an estimated $2.26M trimmed.

  • Seven Eight Capital's largest Q3 2022 buy was Advanced Micro Devices: 110,402 shares worth $7M.
  • Seven Eight Capital added most to Adobe in Q3 2022, an estimated $7.94M increase.
  • Seven Eight Capital's biggest Q3 2022 reduction was Dominion Energy, cutting an estimated $2.26M.
  • Seven Eight Capital fully exited JPMorgan Chase in Q3 2022, selling an estimated $3.68M.
  • Seven Eight Capital's ten largest holdings make up 14% of its $500M portfolio in Q3 2022.
  • Seven Eight Capital opened 305 new positions and closed 206 in Q3 2022.
  • Seven Eight Capital's portfolio value rose 102% quarter-over-quarter to $500M.

Based on Seven Eight Capital's 13F filing for Q3 2022, filed 10 Nov 2022.